Dr. Edward J. Kim
Claim this profileUniversity of California Davis Comprehensive Cancer Center
About Edward J. Kim
Education:
- Earned an A.B. in Chemistry from Harvard University, Cambridge, MA (1997).
- Received M.D. and Ph.D. from Stony Brook University, Stony Brook, NY (2005, 2003 respectively).
Experience:
- Completed Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan, Ann Arbor, MI (2005-2011).
- Serves as Medical Director at UC Davis Comprehensive Cancer Center’s Office of Clinical Research.
- Holds the position of Associate Professor of Medicine, specializing in gastrointestinal malignancies.
- Actively involved in clinical and laboratory research, focusing on novel treatments and patient-derived models for pancreatic cancer.
Area of expertise
Pancreatic Cancer
Edward J. Kim has run 9 trials for Pancreatic Cancer. Some of their research focus areas include:
Liver Cancer
Edward J. Kim has run 6 trials for Liver Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of California Davis Comprehensive Cancer Center
Fremont - Rideout Cancer Center
Clinical Trials Edward J. Kim is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Cetuximab + Pembrolizumab
for Head and Neck Cancer
This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) and/or that has spread from where it first started (primary site) to other places in the body (metastatic). Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Giving cetuximab and pembrolizumab together may be more effective at treating patients with recurrent and/or metastatic HNSCC than pembrolizumab alone.
Recruiting
2 awards
Phase 3
16 criteria
More about Edward J. Kim
Clinical Trial Related
2 years of experience running clinical trials · Led 33 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Edward J. Kim has experience with
- Nivolumab
- Cisplatin
- Gemcitabine
- Nab-paclitaxel
- Radiation Therapy
- Hypofractionated Radiation Therapy
Breakdown of trials Edward J. Kim has run
Pancreatic Cancer
Liver Cancer
Cancer
Gallbladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edward J. Kim specialize in?
Edward J. Kim focuses on Pancreatic Cancer and Liver Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Edward J. Kim currently recruiting for clinical trials?
Yes, Edward J. Kim is currently recruiting for 13 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Edward J. Kim has studied deeply?
Yes, Edward J. Kim has studied treatments such as Nivolumab, Cisplatin, Gemcitabine.
What is the best way to schedule an appointment with Edward J. Kim?
Apply for one of the trials that Edward J. Kim is conducting.
What is the office address of Edward J. Kim?
The office of Edward J. Kim is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.